MIRA Pharmaceuticals Statistics

Total Valuation

MIRA has a market cap or net worth of $21.06 million. The enterprise value is $19.86 million.

Market Cap	21.06M
Enterprise Value	19.86M

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025, after market close.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

MIRA has 16.92 million shares outstanding. The number of shares has increased by 20.70% in one year.

Current Share Class	16.92M
Shares Outstanding	16.92M
Shares Change (YoY)	+20.70%
Shares Change (QoQ)	+0.51%
Owned by Insiders (%)	6.50%
Owned by Institutions (%)	5.72%
Float	12.75M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	15.98
P/TBV Ratio	16.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.86

Current Ratio	12.86
Quick Ratio	11.36
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -355.82% and return on invested capital (ROIC) is -226.16%.

Return on Equity (ROE)	-355.82%
Return on Assets (ROA)	-193.30%
Return on Invested Capital (ROIC)	-226.16%
Return on Capital Employed (ROCE)	-622.44%
Revenue Per Employee	n/a
Profits Per Employee	-$2.64M
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +76.60% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+76.60%
50-Day Moving Average	1.22
200-Day Moving Average	1.20
Relative Strength Index (RSI)	49.60
Average Volume (20 Days)	170,793

Short Selling Information

The latest short interest is 153,955, so 0.91% of the outstanding shares have been sold short.

Short Interest	153,955
Short Previous Month	236,088
Short % of Shares Out	0.91%
Short % of Float	1.21%
Short Ratio (days to cover)	0.63

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-8.06M
Pretax Income	-12.36M
Net Income	-7.92M
EBITDA	n/a
EBIT	-8.06M
Earnings Per Share (EPS)	-$0.50

Full Income Statement

Balance Sheet

The company has $1.21 million in cash and n/a in debt, giving a net cash position of $1.21 million or $0.07 per share.

Cash & Cash Equivalents	1.21M
Total Debt	n/a
Net Cash	1.21M
Net Cash Per Share	$0.07
Equity (Book Value)	1.29M
Book Value Per Share	0.08
Working Capital	1.26M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-6.14M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MIRA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.70%
Shareholder Yield	-20.70%
Earnings Yield	-37.59%
FCF Yield	n/a

Analyst Forecast

The average price target for MIRA is $14.00, which is 1,024.50% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.00
Price Target Difference	1,024.50%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2